超音波創市場－全球產業規模、佔有率、趨勢、機會、預測：按產品類型、傷口類型、最終用戶、地區和競爭對手分類，2021-2031年

全球超音波清創市場預計將從 2025 年的 1.5121 億美元成長到 2031 年的 2.3362 億美元，複合年成長率為 7.52%。

超音波技術的臨床療效是推動這一成長的主要因素。此技術利用低頻聲波和生理食鹽水水清除生物膜和壞死組織，同時保護健康組織。推動該市場發展的主要因素是血管疾病和糖尿病盛行率的不斷上升，以及全球人口老化對非侵入性、選擇性清創治療的需求。歐洲傷口管理協會 (EWMA) 2024 年的數據顯示，在所分析的臨床隊列中，靜脈性腿部潰瘍佔慢性傷口治療的 26%，這凸顯了此類有效治療方法的必要性。

儘管市場促進因素強勁，但由於超音波系統的高昂購置成本以及一次性牙科手機的持續使用費用，該市場仍面臨許多障礙。這些經濟障礙常常限制了超音波系統在地方診所和小規模門診機構的應用，因為預算限制往往迫使這些機構採用傳統的、成本較低的清創方法。此外，各地不同的報銷政策也帶來了經濟上的不確定性，這可能會阻礙這種先進治療方法在醫療服務提供者中的推廣和應用。

市場促進因素

全球超音波創市場的主要驅動力是糖尿病足潰瘍和慢性傷口的激增，這迫切需要先進的解決方案來控制感染和保護組織。該技術因其能夠選擇性地破碎壞死組織並分解生物膜而不損傷健康的肉芽組織而備受青睞。這對於治療血液循環容易受損的糖尿病併發症至關重要。根據國際糖尿病聯盟（IDF）預測，到2024年，全球將有約5.89億糖尿病成人患者，這意味著龐大的患者群體中存在大量複雜的潰瘍，需要進行精準且定期的清創治療以防止截肢。

同時，隨著高齡化社會的加劇，由於與老齡化相關的生理變化常常阻礙創傷治療，對微創清創方法的需求日益成長。老年人通常皮膚脆弱且易患血管疾病，容易出現靜脈潰瘍等慢性損傷，因此不適合進行強力清創。根據發表於2024年4月《亞洲傷口》（Wounds Asia）雜誌上題為「慢性傷口：日益嚴重的公共衛生問題」的報導，美國65歲及以上人群中約有3%患有開放性傷口。這種不斷成長的臨床需求也反映在行業業績中；例如，史密斯醫療（Smith+Nephew）於2025年2月發布的“2024年第四季度及全年財務業績”顯示，其先進傷口管理業務的核心收入成長了12.2%。

市場挑戰

全球超音波清創市場發展面臨的最大障礙是主機的高昂初始投資和一次性牙科手機的持續成本。這筆巨額投資構成了准入門檻，尤其對於預算有限的小規模門診機構和社區診所而言更是如此。與資金雄厚的醫院不同，這些小規模醫療機構（其中許多慢性傷口在基層醫療機構進行管理）往往被迫優先使用傳統的、價格低廉的機械器械，例如刮器和手術刀，而不是採用先進的超音波技術，從而限制了這項技術的廣泛應用。

此外，整個醫療保健系統面臨的經濟壓力也阻礙了對昂貴醫療設備的投資。根據美國居家醫療學會2024年的估計，慢性傷口治療的年度成本在281億美元至968億美元之間。如此龐大的經濟負擔迫使醫療機構管理者實施嚴格的成本控制措施，這往往導致他們放棄資本密集型解決方案。因此，相對於報銷率而言，高昂的擁有成本持續阻礙著超音波清創技術在醫療機構中的廣泛應用。

市場趨勢

全球超音波創術市場的關鍵趨勢是向居家照護和門診環境轉移，這主要受分散式醫療服務需求的驅動。製造商正致力於開發攜帶式電池供電系統，使臨床醫生能夠在非急性護理環境中進行精準的組織清除，從而減少住院時間和相關成本。這種轉變有助於行動不便患者的治療，並符合有利於社區管理的報銷機制。康維特集團於2025年2月發布的2024會計年度財務業績報告也印證了這項變化，報告顯示，由於非醫院領域的強勁應用，其有機收入成長加速至7.7%。

伴隨這一轉變，即時傷口回饋和數位化監測的整合也在不斷發展，將清創設備轉變為智慧診斷平台。開發人員正將感測器和成像技術直接整合到設備中，以幫助在手術過程中準確區分活組織和非活組織。這種治療與診斷的融合增強了臨床決策能力，並能夠追蹤癒合過程的進展。 Spectral AI 於 2025 年 10 月發布的新聞稿「Spectral AI 宣布獲得 760 萬美元資金籌措」充分體現了業界對這項創新的投入，該新聞稿詳細介紹了用於擴展其「DeepView 系統」的資金籌措，該系統將先進的評估技術與治療性介入結合。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球超音波創市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 依產品類型（手持設備、桌上型設備、配件）
  • 傷口類型（慢性傷口、急性傷口、燒傷、其他）
  • 按最終使用者（醫院、門診手術中心、居家醫療機構等）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美超音波清創市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲超音波創術市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區超音波術市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲超音波清創術市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲超音波創市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章：全球超音波清創市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• MISONIX, Inc.
• Smith & Nephew PLC
• Olympus Corporation
• SOring GmbH
• Esacrom SRL
• Hubei CFULL Medical Technology Co., Ltd
• Johnson & Johnson
• Beijing Sonicmed Technologies Co., Ltd.
• Hangzhou Yuanxiang Medical Technology Co., Ltd
• Hainertec（Suzhou）Co., Ltd.

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Ultrasonic Debridement Market is projected to expand from USD 151.21 Million in 2025 to USD 233.62 Million by 2031, registering a CAGR of 7.52%. This growth is underpinned by the clinical efficacy of ultrasonic technology, which employs low-frequency sound waves and a saline medium to remove biofilm and necrotic debris while sparing healthy tissue. The market is primarily driven by the increasing prevalence of vascular diseases and diabetes, alongside an aging global population that demands non-traumatic, selective debridement options. The necessity for such effective therapies is highlighted by data from the European Wound Management Association in 2024, which noted that venous leg ulcers accounted for 26% of treated chronic wounds in analyzed clinical cohorts.

Despite the strong drivers, the market faces significant hurdles due to the high capital costs of ultrasonic systems and the recurring expenses associated with disposable handpieces. These financial barriers frequently restrict adoption in community clinics and smaller outpatient facilities, where budget limitations often dictate the use of traditional, lower-cost debridement methods. Furthermore, inconsistent reimbursement policies across different regions introduce economic uncertainty, which can hinder the widespread availability and uptake of this advanced treatment modality among healthcare providers.

Market Driver

A primary driver for the global ultrasonic debridement market is the surging prevalence of diabetic foot ulcers and chronic wounds, creating an urgent need for advanced solutions that ensure infection control and tissue preservation. The technology is highly valued for its ability to selectively fragment necrotic tissue and disrupt biofilm without damaging healthy granulation tissue, a crucial feature for managing diabetic complications where blood supply is often compromised. According to the International Diabetes Federation, an estimated 589 million adults were living with diabetes globally in 2024, representing a vast patient pool prone to complex ulcerations that require precise and regular debridement to prevent amputation.

Simultaneously, the expanding geriatric population is intensifying the demand for minimally invasive debridement options, as age-related physiological changes often impair wound healing. Older adults frequently suffer from fragile skin and vascular issues, making them susceptible to chronic lesions like venous leg ulcers that are unsuitable for aggressive sharp debridement. An April 2024 article by Wounds Asia titled 'Chronic wounds: a rising public health concern' indicated that approximately 3% of the U.S. population over age 65 suffers from open wounds. This growing clinical need is reflected in sector performance; for instance, Smith+Nephew's 'Fourth Quarter and Full Year 2024 Results' from February 2025 reported a 12.2% underlying revenue growth in their Advanced Wound Management business.

Market Challenge

The most significant challenge hindering the growth of the global ultrasonic debridement market is the high initial capital expenditure required for consoles and the recurring costs of disposable handpieces. This substantial financial investment acts as a barrier to entry, particularly for smaller outpatient facilities and community clinics that operate with limited budgets. Unlike well-funded hospitals, these smaller providers are often forced to forego advanced ultrasonic technology in favor of traditional, less expensive mechanical tools such as curettes or scalpels, thereby restricting the technology's reach in primary care settings where many chronic wounds are managed.

Furthermore, broader economic pressures on healthcare systems exacerbate the hesitation to invest in premium medical devices. According to the American Academy of Home Care Medicine in 2024, the estimated annual cost for managing chronic wounds ranged from $28.1 billion to $96.8 billion. This immense financial burden compels facility administrators to enforce strict cost-control measures, often resulting in the rejection of capital-intensive solutions. Consequently, the high cost of ownership relative to reimbursement rates continues to stifle the expansion of ultrasonic debridement into the wider healthcare landscape.

Market Trends

A pivotal trend in the global ultrasonic debridement market is the shift toward home care and outpatient settings, driven by the demand for decentralized healthcare delivery. Manufacturers are increasingly focusing on developing portable, battery-operated systems that allow clinicians to perform precise tissue removal outside of acute care environments, helping to reduce hospital lengths of stay and associated costs. This transition supports the treatment of immobile patients and aligns with reimbursement structures favoring community-based management, a shift evidenced by Convatec Group Plc's 'FY24 Results' in February 2025, which reported an accelerated organic revenue growth of 7.7% due to robust adoption in non-hospital sectors.

Concurrent with this shift is the integration of real-time wound feedback and digital monitoring, transforming debridement devices into intelligent diagnostic platforms. Developers are embedding sensors and imaging technologies directly into devices to help practitioners accurately distinguish between viable and non-viable tissue during procedures. This convergence of therapy and diagnostics enhances clinical decision-making and allows for longitudinal tracking of healing. The industry's commitment to this innovation is highlighted by Spectral AI, Inc.'s October 2025 press release, 'Spectral AI Announces $7.6 Million Offering', detailing the funding secured to expand its DeepView System, which couples advanced assessment technology with therapeutic intervention.

Key Market Players

• MISONIX, Inc.
• Smith & Nephew PLC
• Olympus Corporation
• SOring GmbH
• Esacrom S.R.L.
• Hubei CFULL Medical Technology Co., Ltd
• Johnson & Johnson
• Beijing Sonicmed Technologies Co., Ltd.
• Hangzhou Yuanxiang Medical Technology Co., Ltd
• Hainertec (Suzhou) Co., Ltd.

Report Scope

In this report, the Global Ultrasonic Debridement Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Ultrasonic Debridement Market, By Product Type

• Handheld Devices
• Desktop Devices
• Accessories

Ultrasonic Debridement Market, By Wound Type

• Chronic Wounds
• Acute Wounds
• Burn Wounds
• Others

Ultrasonic Debridement Market, By End User

• Hospitals
• Ambulatory Surgical Centers
• Homecare Settings
• Others

Ultrasonic Debridement Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Ultrasonic Debridement Market.

Available Customizations:

Global Ultrasonic Debridement Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Ultrasonic Debridement Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Handheld Devices, Desktop Devices, Accessories)
  • 5.2.2. By Wound Type (Chronic Wounds, Acute Wounds, Burn Wounds, Others)
  • 5.2.3. By End User (Hospitals, Ambulatory Surgical Centers, Homecare Settings, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Ultrasonic Debridement Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By Wound Type
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Ultrasonic Debridement Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By Wound Type
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Ultrasonic Debridement Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By Wound Type
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Ultrasonic Debridement Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By Wound Type
      • 6.3.3.2.3. By End User

7. Europe Ultrasonic Debridement Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By Wound Type
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Ultrasonic Debridement Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By Wound Type
      • 7.3.1.2.3. By End User
  • 7.3.2. France Ultrasonic Debridement Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By Wound Type
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Ultrasonic Debridement Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By Wound Type
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Ultrasonic Debridement Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By Wound Type
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Ultrasonic Debridement Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By Wound Type
      • 7.3.5.2.3. By End User

8. Asia Pacific Ultrasonic Debridement Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By Wound Type
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Ultrasonic Debridement Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By Wound Type
      • 8.3.1.2.3. By End User
  • 8.3.2. India Ultrasonic Debridement Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By Wound Type
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Ultrasonic Debridement Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By Wound Type
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Ultrasonic Debridement Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Type
      • 8.3.4.2.2. By Wound Type
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Ultrasonic Debridement Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Type
      • 8.3.5.2.2. By Wound Type
      • 8.3.5.2.3. By End User

9. Middle East & Africa Ultrasonic Debridement Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By Wound Type
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Ultrasonic Debridement Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By Wound Type
      • 9.3.1.2.3. By End User
  • 9.3.2. UAE Ultrasonic Debridement Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By Wound Type
      • 9.3.2.2.3. By End User
  • 9.3.3. South Africa Ultrasonic Debridement Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By Wound Type
      • 9.3.3.2.3. By End User

10. South America Ultrasonic Debridement Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By Wound Type
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Ultrasonic Debridement Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By Wound Type
      • 10.3.1.2.3. By End User
  • 10.3.2. Colombia Ultrasonic Debridement Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By Wound Type
      • 10.3.2.2.3. By End User
  • 10.3.3. Argentina Ultrasonic Debridement Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By Wound Type
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Ultrasonic Debridement Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. MISONIX, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Smith & Nephew PLC
• 15.3. Olympus Corporation
• 15.4. SOring GmbH
• 15.5. Esacrom S.R.L.
• 15.6. Hubei CFULL Medical Technology Co., Ltd
• 15.7. Johnson & Johnson
• 15.8. Beijing Sonicmed Technologies Co., Ltd.
• 15.9. Hangzhou Yuanxiang Medical Technology Co., Ltd
• 15.10. Hainertec (Suzhou) Co., Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer